Vergoeding 2020-2024 voor ATC-subgroep L01X : Overige oncolytica
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023* | 2024* | |
|---|---|---|---|---|---|
| L01XA Platinaverbindingen | 2.012.992 | 2.808.122 | 2.213.021 | 2.113.984 | 1.558.562 |
| L01XB Methylhydrazinen | 122.922 | 124.321 | 131.986 | 122.908 | 72.340 |
| L01XD Sensitizers bij fotodynamische en radiotherapie | 956.894 | 931.632 | 655.919 | 603.650 | 632.451 |
| L01XF Retinoiden bij kanker | 209.270 | 183.111 | 147.417 | 253.010 | 176.226 |
| L01XG Proteasoomremmers | 33.075.439 | 26.329.043 | 19.910.267 | 20.212.508 | 21.719.140 |
| L01XH Hdac-remmers | 4.699 | . | . | . | . |
| L01XJ Hedgehog-signaalroute remmers | 725.718 | 845.785 | 951.287 | 1.367.636 | 1.572.465 |
| L01XK Parp-remmers | 16.125.747 | 28.464.397 | 32.792.264 | 30.812.965 | 25.833.463 |
| L01XL Oncolytische cel- en gentherapie | 20.734.513 | 27.514.784 | 37.756.222 | 33.053.260 | 26.841.112 |
| L01XM Idh-remmers | . | . | . | 52.647 | 1.755.401 |
| L01XX Overige oncolytica | 14.744.873 | 18.246.505 | 20.879.834 | 24.874.364 | 27.194.878 |
| L01XY Combinaties van oncolytica | 90.008 | 749.083 | 384.126 | 345.183 | 17.004 |
| Totaal | 88.803.077 | 106.196.781 | 115.822.343 | 113.812.115 | 107.373.042 |